EUVIMEDEUVIMED entdecken
Open Access · CC0

Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage

Joshua L Cherry iD

eLife · 2026

DOI: 10.7554/elife.107256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Joshua L Cherry. Beteiligte Einrichtung: Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, United States. Hauptthemen laut MEDLINE: Heterozygote, Major Histocompatibility Complex, Genetic Variation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several theoretical studies have concluded that heterozygote advantage makes at most a minor contribution to MHC diversity. Siljestam and Rueffler (2024) recently presented models in which heterozygote advantage alone can lead to realistically high diversity. Here I argue that heterozygote advantage cannot by itself explain MHC diversity, and that its contribution to diversity is unlikely to be large in most species. I first show that the high diversity reported by Siljestam and Rueffler is so sensitive to parameter values that the underlying phenomenon cannot explain the widespread diversity of MHC genes. I then consider a fundamental problem with explaining MHC diversity by heterozygote advantage alone: selective forces that favored heterozygotes would lead to the evolution of haplotypes having much higher fitness when homozygous, diminishing or eliminating heterozygote advantage. Diversity maintained by another force, however, might bring about adaptation to the more common heterozygous state at the expense of homozygous fitness. Thus, substantial heterozygote advantage may arise as a consequence of MHC diversity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeterozygoteMajor Histocompatibility ComplexGenetic VariationAnimalsSelection, GeneticHaplotypesEvolution, MolecularModels, GeneticHumans

Stichwörter der Autor:innen

MHCdiversityevolutionary biologyheterozygote advantageimmunologyinflammationmajor histocompatibility complexnone

Autor:innen und Institutionen

  • Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, United States.

ORCID-Profile: Joshua L Cherry

Zitieren

APA

Cherry, J. L. (2026). Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage. eLife. https://doi.org/10.7554/elife.107256

Vancouver

Cherry JL. Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage. eLife. 2026. doi:10.7554/elife.107256

BibTeX
@article{Cherry2026,
  author = {Cherry, Joshua L},
  title = {Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage},
  journal = {eLife},
  year = {2026},
  doi = {10.7554/elife.107256}
}
Kostenlos starten →